Significance of the volume of fetomaternal hemorrhage after performing prenatal invasive tests

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 1, 2011, Pages 38-42

  Subira D ^a   Uriel, M ^b   Serrano, C ^c   Castanon S ^a   Gonzalo, R ^a   Illan J ^c   Plaza, J ^a   Roman A ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c Unilabs   (France)

Author keywords

amniocentesis; fetal hemoglobin; fetomaternal hemorrhage; flow cytometry; prenatal invasive tests

Indexed keywords

HEMOGLOBIN F; MONOCLONAL ANTIBODY;

ADULT; AMNIOCENTESIS; ARTICLE; BLEEDING; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CHORION VILLUS SAMPLING; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS CELL; FLOW CYTOMETRY; GESTATION PERIOD; HEMOGLOBIN ANALYSIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AMNIOCENTESIS; CASE-CONTROL STUDIES; CHORIONIC VILLI SAMPLING; ERYTHROCYTES; FEMALE; FETAL HEMOGLOBIN; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PREGNANCY; RISK ASSESSMENT; YOUNG ADULT;

EID: 78650811164     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20548     Document Type: Article

References (22)

1. Mujezinovic F, Alfirevic Z,. Procedure related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687 - 694.
2. Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK,. Risk factors for procedure related fetal losses after mid trimester genetic amniocentesis. Prenat Diagn 2006; 26: 925 - 930.
3. Tabor A, Vestergaard CH, Lidegaard Ø,. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11 year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19 - 24.
4. von Dadelszen P, Sermer M, Hillier J, Allen LC, Fernandes BJ, Johnson JA, Shime J, Winsor EJ, Ryan G,. A randomised controlled trial of biopsy forceps and cannula aspiration for transcervical chorionic villus sampling. BJOG 2005; 112: 559 - 566.
5. Dziegiel MH, Nielsen LK, Berkowicz A,. Detecting fetomaternal hemorrhage by flow cytometry. Curr Opin Hematol 2006; 13: 490 - 495.
6. Chen J, Davis B, Wood B, Warzynski MJ,. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002; 50: 285 - 290.
7. Pelikan DM, Scherjon SA, Mesker WE, de Groot Swings GM, Brouwer Mandema GG, Tanke HJ, Kanhai HH,. Quantification of fetomaternal hemorrhage: a comparative study of the manual and automated microscopic Kleihauer Betke tests and flow cytometry in clinical samples. Am J Obstet Gynecol 2004; 191: 551 - 557.
8. Mundee Y, Bigelow NC, Davis BH, Porter JB,. Simplified flow cytometric method for fetal hemoglobin containing red blood cells. Cytometry 2000; 42: 389 - 393.
9. Kennedy GA, Shaw R, Just S, Bryson G, Battistutta F, Rowell J, Williams B,. Quantification of feto maternal hemorrhage by flow cytometry. Transfus Med 2003; 13: 25 - 33.
10. Mollison PL,. Quantitation of transplacental haemorrhage. BMJ 1972; 3: 31-34.
11. Al Mufti R, Hambley H, Farzaneh F, Nicolaides KH,. Distribution of fetal erythroblasts in maternal blood after chorionic villous sampling. BJOG 2003; 110: 33 - 38. (Pubitemid 36034291)
12. Chitrit Y, Caubel P, Lusina D, Boulanger M, Balledent F, Schwinte AL, Herrero R,. Detection and measurement of fetomaternal hemorrhage following diagnostic cordocentesis. Fetal Diagn Ther 1998; 13: 253 - 256.
13. Milman N, Bergholt T, Byg KE, Eriksen L, Hvas A M,. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Hematol 2007; 79: 39 - 46.
14. Sebring E, Polesky H,. Fetomaternal hemorrhage, incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990; 30: 344 - 357.
15. Von Stein GA, Munsick RA, Stiver K, Ryder K,. Fetomaternal hemorrhage in threatened abortion. Obstet Gynecol 1992; 79: 383 - 386.
16. Zhong XY, Steinborn A, Sohn C, Holzgreve W, Hahn S,. High levels of circulatory erythroblasts and cell free DNA prior to intrauterine fetal death. Prenat Diagn 2006; 26: 1272 - 1273.
17. Al Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH,. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000; 15: 218 - 221.
18. Mavrou A, Kouvidi E, Antsaklis A, Souka A, Kitsiou Tzeli S, Kolialexi A,. Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications. Prenat Diagn 2007; 27: 150 - 153.
19. Sohda S, Arinami T, Hamada H, Nakauchi H, Hamaguchi H, Kubo T,. The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. Prenat Diagn 1997; 17: 743 - 752.
20. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH,. Kinetics of fetal cellular and cell free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41: 1524 - 1530.
21. Persson PH, Weldner BM,. Intra uterine weight curves obtained by ultrasound. Acta Obstet Gynecol Scand 1986; 65: 169 - 173.
22. Hoyer JD, Penz CS, Fairbanks VF, Hanson CA, Katzmann JA,. Flow cytometric measurement of hemoglobin F in RBCs: diagnostic usefulness in the distinction of hereditary persistence of fetal hemoglobin (HPFH) and hemoglobin S hPFH from other conditions with elevated levels of hemoglobin F. Am J Clin Pathol 2002; 117: 857 - 863.